Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
77.78B | 78.61B | 82.92B | 75.95B | 73.62B | 80.22B | Gross Profit |
13.87B | 14.18B | 14.85B | 15.66B | 16.00B | 16.70B | EBIT |
-468.00M | -958.00M | -713.00M | 855.00M | 1.57B | 1.60B | EBITDA |
2.60B | -1.22B | 2.13B | 5.42B | 7.29B | 5.87B | Net Income Common Stockholders |
2.06B | -8.21B | -1.20B | 1.52B | 3.21B | 1.90B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.15B | 6.85B | 6.89B | 7.59B | 8.13B | 7.01B | Total Assets |
84.17B | 82.66B | 86.22B | 80.12B | 76.86B | 72.25B | Total Debt |
14.65B | 14.65B | 11.10B | 5.20B | 5.20B | 5.22B | Net Debt |
7.50B | 7.80B | 4.21B | -2.39B | -2.93B | -1.79B | Total Liabilities |
43.36B | 43.11B | 40.02B | 32.40B | 30.48B | 30.90B | Stockholders Equity |
40.81B | 39.55B | 46.20B | 47.73B | 46.38B | 41.35B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.37B | -5.91B | -1.41B | -733.00M | 2.86B | Operating Cash Flow |
0.00 | 1.88B | -1.07B | 4.71B | 4.51B | 7.55B | Investing Cash Flow |
0.00 | -3.79B | -4.48B | -5.03B | -2.83B | -4.59B | Financing Cash Flow |
0.00 | 1.76B | 4.55B | -860.00M | -650.00M | -1.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $524.89B | 6.99 | 9.02% | 2.89% | 11.10% | 11.55% | |
74 Outperform | $4.29T | 14.76 | 7.90% | 3.26% | 2.70% | -13.42% | |
74 Outperform | ¥424.10B | 5.67 | 14.57% | 4.51% | 4.01% | -22.73% | |
72 Outperform | $278.68B | 11.10 | 7.16% | 4.83% | 10.04% | -13.43% | |
57 Neutral | ¥19.88B | 45.09 | 1.45% | -1.72% | ― | ||
49 Neutral | $1.98B | -1.10 | -21.24% | 3.61% | 1.31% | -31.23% | |
45 Neutral | ¥220.55B | 11.14 | -1.23% | 4.79% | 7.76% | -171.50% |